Indiana § 16-46-7-10 Study and report

Indiana Statutes

§ 16-46-7-10 — Study and report

Indiana·Title 16 HEALTH·Art. 46 STATE HEALTH GRANTS AND PROGRAMS·Ch. 7 Sickle Cell Anemia Grant Program

(a)Before July 1, 2019, and on a biennial basis thereafter, the state department, with the assistance of:

(1)the Indiana minority health coalition;

(2)health care providers that treat individuals with sickle cell disease;

(3)individuals diagnosed with sickle cell disease; and

(4)representatives of community based organizations that serve individuals with sickle cell disease; shall perform a study to determine the prevalence, impact, and needs of individuals with sickle cell disease and sickle cell trait in Indiana.

(b)The study must include the following:

(1)The prevalence, by geographic location, of individuals diagnosed with sickle cell disease in Indiana.

(2)The prevalence, by geographic location, of individuals diagnosed as sickle cell trait carriers in Indiana.

(3)The availab

Free access — add to your briefcase to read the full text and ask questions with AI

(a) Before July 1, 2019, and on a biennial
basis thereafter, the state department, with the assistance of:
(1) the Indiana minority health coalition;
(2) health care providers that treat individuals with sickle cell
disease;
(3) individuals diagnosed with sickle cell disease; and
(4) representatives of community based organizations that serve
individuals with sickle cell disease;
shall perform a study to determine the prevalence, impact, and needs
of individuals with sickle cell disease and sickle cell trait in Indiana.
(b) The study must include the following:
(1) The prevalence, by geographic location, of individuals
diagnosed with sickle cell disease in Indiana.
(2) The prevalence, by geographic location, of individuals
diagnosed as sickle cell trait carriers in Indiana.
(3) The availability and affordability of screening services in
Indiana for sickle cell trait.
(4) The location and capacity of the following for the treatment of
sickle cell disease and sickle cell trait carriers:
(A) Treatment centers.
(B) Clinics.
(C) Community based social service organizations.
(D) Medical specialists.
(5) The unmet medical, psychological, and social needs
encountered by individuals in Indiana with sickle cell disease.
(6) The underserved areas of Indiana for the treatment of sickle
cell disease.
(7) Recommendations for actions to address any shortcomings in
Indiana identified under this section.
(c) The state department shall transmit a study performed under this
section in an electronic format under IC 5-14-6 to the general assembly.